Sign Out
Tecentriq 840 mg concentrate for solution for infusion: One 14 mL vial of concentrate contains 840 mg of atezolizumab*.
Tecentriq 1 200 mg concentrate for solution for infusion: One 20 mL vial of concentrate contains 1,200 mg atezolizumab*.
After dilution (see Special precautions for disposal and other handling under Cautions for Usage), the final concentration of the diluted solution should be between 3.2 and 16.8 mg/mL.
*Atezolizumab is an Fc-engineered, humanised IgG1 anti-programmed death-ligand 1 (PD-L1) monoclonal antibody produced in Chinese hamster ovary cells by recombinant DNA technology.
Excipients/Inactive Ingredients: L-histidine, Glacial acetic acid, Sucrose, Polysorbate 20, Water for injections.
